Eikon Therapeutics, Inc. (EIKN)

NASDAQ: EIKN · Real-Time Price · USD

5.98

-0.06 (-0.99%)

Nov 13, 2026, 4:00 PM EST - Market closed

Eikon Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-354.25	-314.43	-260.34	-265.74
Net Income	-337.13	-333.64	-243.81	-242
Earnings Per Share	-9.28	-115.29	-96.76	-119.43
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	461.72	335.98	220.11	430.41
Total Debt	249.55	257.32	202.46	31.74
Net Cash (Debt)	212.17	78.66	17.65	398.68
Net Cash Growth	57.02%	345.59%	-95.57%	-
Net Cash Per Share	5.84	27.18	7.01	196.75

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-265.67	-188.52	-134.8	-190.85
Capital Expenditures	-1	-46.74	-84.8	-28.51
Free Cash Flow	-266.67	-235.26	-219.6	-219.36
Free Cash Flow Growth	-	-	-	-